As of 2026-09-17, the Intrinsic Value of Revive Therapeutics Ltd (RVV.CN) is -0.13 CAD. This RVV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Revive Therapeutics Ltd is -734.55%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Revive Therapeutics Ltd (RVV.CN) is overvalued by 734.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.13 - -0.13 | -0.13 | -734.55% |
| P/E | (0.71) - (0.88) | (0.89) | -4536.8% |
| DDM - Stable | (0.24) - (1.47) | (0.85) | -4363.5% |
| DDM - Multi | (0.00) - (0.02) | (0.01) | -133.5% |
| Market Cap (mil) | 10.46 |
| Beta | -6.52 |
| Outstanding shares (mil) | 523.20 |
| Enterprise Value (mil) | 10.52 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.61% |
| Cost of Debt | 5.00% |
| WACC | 7.58% |